Large-scale testing (Phase 3)Looking for participantsNCT06443606
What this trial is testing
Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
Who this might be right for
BPCNon Optimal Response to UDCA
Assistance Publique - Hôpitaux de Paris 108